The Potential Regulation of L1 Mobility by RNA Interference by Horman, Shane R. et al.
Hindawi Publishing Corporation
Journal of Biomedicine and Biotechnology
Volume 2006, Article ID 32713, Pages 1–8
DOI 10.1155/JBB/2006/32713
ReviewArticle
The Potential Regulation of L1 Mobility by RNA Interference
Shane R. Horman,1 Petr Svoboda,2 and Eline T. Luning Prak1
1Department of Pathology and Laboratory Medicine, School of Medicine, University of Pennsylvania, Philadelphia,
PA 19104-6055, USA
2Friedrich Miescher Institute for Biomedical Research, Maulbeerstrasse 66, 4058 Basel, Switzerland
Received 6 August 2005; Revised 12 December 2005; Accepted 20 December 2005
The hypothesis that RNA interference constrains L1 mobility seems inherently reasonable: L1 mobility can be dangerous and
L1 RNA, the presumed target of RNAi, serves as a critical retrotransposition intermediate. Despite its plausibility, proof for this
hypothesis has been diﬃcult to obtain. Studies attempting to link the L1 retrotransposition frequency to alterations in RNAi
activity have been hampered by the long times required to measure retrotransposition frequency, the pleiotropic and toxic eﬀects
of altering RNAi over similar time periods, and the possibility that other cellular machinery may contribute to the regulation
of L1s. Another problem is that the commonly used L1 reporter cassette may serve as a substrate for RNAi. Here we review the
L1-RNAi hypothesis and describe a genetic assay with a modiﬁed reporter cassette that detects approximately 4 times more L1
insertions than the conventional retrotransposition assay.
Copyright © 2006 Shane R. Horman et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
RNAi SILENCING OF TRANSPOSABLE ELEMENTS
RNAi is an evolutionarily conserved process of sequence-
speciﬁc posttranscriptional gene silencing (reviewed in [1]).
Double-stranded RNA (dsRNA) is cleaved by the ribonu-
clease DICER into small interfering RNA species (siRNAs).
SiRNA molecules, in turn, target complementary RNA se-
quences for destruction (reviewed in [2]). RNAi is postu-
lated to play a role in the silencing of transposable elements
and viruses that produce dsRNA [3, 4]. One line of evidence
linking RNAi to repressed transposition comes from the ne-
matode, Ce l e g a n s[5, 6]. Tc1 elements, a class of DNA trans-
posons,mobilizeinsomaticcells,butaresilencedinthegerm
line of Ce l e g a n s .An u m b e ro fm u t a n tCe l e g a n sstrains that
have lost this silencing have also lost the ability to execute
RNAi (though there were also RNAi mutants that lacked this
transposon mobilization phenotype) [5]. The identiﬁcation
of speciﬁc genes, which when mutated show activation of
germline transposition, indicates that an active transposon-
silencing process exists in the germline [5, 6]. Another line
of evidence linking RNAi (or a mechanism similar to RNAi)
to the regulation of transposable elements involves the I-
factor in Drosophila. Mobilization of the I-factor (an L1-like
non-LTR retrotransposon) is regulated at least in part by
a homology-dependent silencing mechanism in the female
germline [7, 8]. This silencing mechanism has been linked to
aseriesofmoleculesthatareimplicatedintheRNAipathway,
including the Argonaute protein PIWI [9, 10].
By analogy, perhaps a sequence-dependent process of
mobile element silencing, such as RNAi, is used to regulate
L1mobility. Aswiththeabove-mentioned examples, thereg-
ulation of L1 mobility may be particularly relevant in the
germline and in embryos. Mobility in the germline or in
embryos could result in inheritance of the new insertion.
These sites are also where L1s are believed to be most active
[11–14]. Other mechanisms for recognizing and responding
to dsRNA, such as RNase L and PKR-mediated responses,
can cause apoptosis. While apoptosis seems like a reason-
able strategy for dealing with a wayward somatic cell, in the
germline or early embryo, apoptosis could be detrimental to
the ﬁtness of the organism [14, 15]. Here we explore the the-
sis that the mobility of human L1s is regulated by RNAi.
L1 RETROTRANSPOSITION: HAZARDS
AND CONSTRAINTS
The human genome contains roughly half a million long in-
terspersed elements (L1s) that collectively account for 17%
o fitsmass[16].MostnewL1insertionsare“deadonarrival”
due to 5  truncation and nearly all but perhaps 60–100 L1 se-
quencesinthehumangenomeareinactiveduetotruncation,
inversion, or mutation [17].2 Journal of Biomedicine and Biotechnology
As discussed elsewhere in this issue, retrotransposition
can be hazardous because L1s can insert into genes, alter
gene expression, shuﬄe exons, transduce 3  ﬂanking sequen-
ces,mobilizeAluelements,andtheirreplicativemobilization
adds signiﬁcant DNA mass to the genome [18–24]. L1 inser-
tions and recombination events involving genomic L1 and
Aluinsertionshavebeenreportedinanumberofgeneticdis-
orders (reviewed in [25]). Although it is possible that some
functions of L1 are beneﬁcial to mammals (a most interest-
ing recent demonstration involves the potential role of L1s
as diversity generators in the CNS, [26]), most germline L1
insertions are likely to be neutral or negatively selected. Neg-
ative selection of L1s is suggested by the higher frequencies
of full-length human L1 insertions on the sex chromosomes
than the autosomes (the former not being as able as the latter
to undergo purifying selection) and by the dominance and
limited periods of activity of single L1 subfamilies in some
primate lineages [27, 28].
L1 mobility in mammals appears to be actively con-
strained. An indirect line of evidence for this constraint is
that diﬀerent cell types exhibit diﬀerent rates of retrotrans-
position, ranging from 30% or higher in some transformed
cell lines to fewer than one per million cells. In the mouse,
the rate of germline retrotransposition events using an L1-
EGFP transgene is approximately one event in 100 oﬀspring
[11, 13]. Analysis of L1 transcription, protein production
and retrotransposition, reveals diﬀerent levels of L1 activity
in diﬀerent cell types, with highest levels of activity noted in
germ cells, embryonal cells, and recently neuronal cells [11–
13, 26, 29, 30]. The factor(s) that assist L1 mobilization in
some cell lines, but not others, are not known.
L1 RNA IS A LOGICAL TARGET FOR
LIMITING L1 MOBILITY
RNA is a logical target for cellular machinery to protect
against unwanted L1 proliferation. L1 RNA is required and
may be rate-limiting for retrotransposition. In cell-culture-
based assays with tagged human L1 elements, it has been
shown that a decrease in L1 mRNA leads to a decrease in L1
retrotransposition frequencies, lending support to the idea
that L1 activity can be limited by regulating L1 transcript
abundance [31, 32]. L1 RNA is critical for retrotransposition
because it encodes the necessary ORF1 and ORF2 proteins,
which act preferentially upon the RNA that encoded them
[33, 34]. This eﬀect, termed cis preference, may allow active
L1s a greater proliferative advantage than retroelements that
mobilize in transbecausetrans-mobilization can resultin the
expansion of mutated rather than active elements. RNAi may
be able to counter this potential advantage of cis preference
by using nonfunctional L1 RNAs to inhibit functional L1s.
On the other hand, the high copy number of L1 insertions
in mammals may have been selected for L1s that are inef-
ﬁciently regulated by RNAi. If RNAi silences L1s, it does not
dosowithperfecteﬃciencysinceL1transcriptsaredetected,
and some L1s can still mobilize in the human genome.
How (or even if) L1 RNA is recognized by cellular ma-
chinery is unknown. If RNAi limits human L1 retrotrans-
position, the most obvious possibility is that RNAi post-
transcriptionally targets L1 mRNA. The presumed trigger
for RNAi is double-stranded RNA (dsRNA), although other
forms of sequence-speciﬁc recognition or unusual RNA sec-
ondary structure are possible. DsRNA has been documented
to be the target of RNAi-induced transposon silencing in
other species, most notably the Tc1 DNA transposon in C
elegans [5, 6]. Read-through transcription of dispersed Tc1
copies can form dsRNA as a result of “snap-back” of their
terminal inverted repeats (TIRs), which are complementary
in sequence. Human L1 retrotransposons are not ﬂanked
by complementary TIRs, however there is considerable nu-
cleotide sequence similarity between active L1s [35]. This
high level of sequence similarity amongst active human L1
elements might allow only a few L1 dsRNA molecules to si-
lence many genomic L1s. Sense and antisense L1 transcripts
have been documented in human teratocarcinoma cells [36].
There are two reports suggesting the presence of long L1
dsRNA [37, 38], although thus far an unequivocal demon-
stration of Dicer-derived L1 siRNAs or miRNAs from mam-
malian cells has remained elusive [39–41].
There are several ways in which L1 dsRNA could be
formed (see Figure 1). First, antisense L1 RNA could arise as
a read-through transcript from a heterologous promoter ele-
ment (Figure 1(a)). If sense and antisense transcripts orig-
inating from diﬀerent loci could form dsRNA, even inac-
tive copies of L1 could contribute to the loss of L1 mobil-
ity (Figure 1(b)). As the genomic burden of L1 copies in-
creases, the level of L1 repression might also increase. On
the other hand, highly eﬃcient silencing of all L1 copies
in trans could be problematic since L1s may inﬂuence the
human transcriptome signiﬁcantly (reviewed in [20]). An
alternative is to selectively target L1 dsRNA that arises in
cis. In this connection, the L1 5 UTR has antisense pro-
moter activity at positions 400–600, providing an additional
source of antisense L1 RNA (Figure 1(c))[ 42, 43]. RNAi tar-
geting the L1 5 UTR would be expected to selectively re-
strain full-length (and therefore more likely to be active) el-
ements. Finally, L1 dsRNA can originate from the transcrip-
tion of inverted repeats (Figure 1(d)). A high copy number
of L1 sequences in mammalian genomes increases the like-
lihood of generating inverted repeats either by genome re-
arrangements or by insertions of L1 elements into or near
themselves [44]. We conducted a simple search for long in-
verted repeats (>200bp) in the human genome, and a pre-
liminary analysis of several chromosomes indicates that the
whole genome contains tens of perfect inverted repeats of
L1 sequences. Transcription of such inverted repeats results
in an eﬃcient dsRNA formation because this dsRNA fold-
ing is a ﬁrst-order reaction. Although the focus here is on
dsRNA, there may be other forms of L1 RNA that are rec-
ognized. L1 RNA species are heterogeneous due to vari-
able5  truncation, premature polyadenylation, and inversion
[45, 46].Shane R. Horman et al 3
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Figure 1: Generation of L1 dsRNA. L1 dsRNA could arise from diﬀerent transcripts (shown in Figures 1(a), 1(b),a n d1(c))o rf r o mt h e
same transcript (shown in Figure 1(d)). (a) An L1 transcript originates from the internal 5 UTR promoter, producing a sense-strand RNA.
Neighboring the same element, an antisense-oriented heterologous promoter produces a read-through transcript that includes antisense L1
RNA. (b) An L1 is transcribed producing sense RNA and another L1 insertion, elsewhere in the genome, is transcribed oﬀ of a heterologous
promoter yielding an antisenseRNA.(c)AnL1 istranscribed oﬀof its 5 UTR producingasensetranscript,while antisensepromoter activity
of the 5 UTR produces an antisense transcript. (d) If an L1 inserts near another L1 sequence in the genome, it may be possible to create a
hairpin. The ﬁgure shows two full-length L1 sequences facing each other, although it should be noted that hairpins could also form between
truncated L1 copies that face each other, as long as there is a transcript that extends between the copies. DNA strands are shown with solid
lines and RNA with dashed lines. In the scenario depicted, transcripts oﬀ of either DNA strand extending through the two L1 sequences will
give rise to self-complementary regions: the forward facing L1 and the reverse complementary sequence of L1 on the same RNA strand can
base pair, forming hairpins (dashed vertical lines) with stretches of dsRNA.
HOW MIGHT RNAi SILENCE L1s?
The most obvious possibility is that RNAi limits L1 retro-
transposition by decreasing the amount of L1 RNA. In this
case, disruption of RNAi should increase L1 RNA levels and
result in an increased retrotransposition frequency. The rela-
tionshipbetweenRNAiandrepressionoftheLTRretrotrans-
posons MuERV-L and intracisternal A-particle (IAP) was
recently investigated in early mouse embryos [47]. Knock-
ing down DICER (with siRNA or dsRNA) resulted in a
50% increase in the abundance of MuERV-L and IAP tran-
scripts [47]. Recently, conditional dicer knock-out ES cells
were shown to exhibit slightly increased levels of IAP and
L1 transcripts compared to dicer wild-type cells [48]. In fur-
ther support of this theory, L1 retrotransposons can form
dsRNA that is cleaved into siRNAs by DICER in cultured
cells [49, 50]. This analysis reveals that L1s can serve as tar-
gets for RNAi, but does not address whether they do so in
nature.
Another possibility is that one or more components of
the RNAi machinery acts by silencing L1 insertions in chro-
matin via methylation of L1 DNA [47]. Methylation has
been proposed as a genomic defense against transposable el-
ements and may function in an RNAi-dependent or inde-
pendent manner to limit L1 transcription [53, 54]. Methyla-
tion of the L1 5 UTR has been demonstrated in diﬀerent cell
types [55, 56]. Treatment of 3T3 cells with 5-azacytidine, a
pyrimidine analog that inhibits DNA methyltransferase, in-
creases L1 transcript abundance [57]. In mice, inactivation
of methylases can result in mobilization of retrotransposons
including IAP elements and L1s [58, 59]. On the other hand,
methylation was not observed in response to stable dsRNA
expression in murine oocytes [47]. Consistent with the latter
observation, a recent analysis in human cancer cells suggests
that RNAi-mediated transcriptional silencing can arise inde-
pendently of methylation [60].
Another nonmutually exclusive possibility is that RNAi
participates in altering chromatin accessibility. Heterochro-
matic silencing and histone methylation have been tied to
the RNAi pathway in Sp o m b e[61, 62]. Moreover, in the ﬁl-
amentous fungus, Neurospora crassa, repression of the L1-
like retrotransposon Tad is dependent upon the Argonaute
protein QDE2 and DICER [63]. DNA and histone methy-
lation have also been implicated in transposon control in4 Journal of Biomedicine and Biotechnology
Arabidopsis [64]. In certain yeast and plant species, hete-
rochromatin formation may be directed by siRNAs in an
Argonaute complex with similarities to the RNA-induced si-
lencing complex, suggesting that the processes of PTGS and
transcriptionalgenesilencingareintertwined[63].Although
plant L1-like elements diﬀer from mammalian L1 elements,
a similar means of mammalian L1-associated chromatin si-
lencing may be at work.
It is possible that RNAi acts upon L1s using all of these
pathways: degradation of L1 RNA (which limits the produc-
tion of new insertions), modiﬁcation of L1 DNA sequences
and chromatin silencing (which should limit the activity of
new or existing functional L1s). The containment of L1s in
regions of silenced chromatin provides protection by sup-
pressing their transcription, mobility, and recombinational
activity [65–67].
ESTABLISHING A FUNCTIONAL LINK BETWEEN
RNAi AND L1 RETROTRANSPOSITION
Currently, the only direct evidence linking RNAi to the re-
pression of L1 elements in mammals is a slightly increased
level of L1 transcripts in dicer deﬁcient mouse ES cells [48].
Current eﬀorts to explore L1 regulation by RNAi in mam-
mals are focused on three areas: (i) demonstration of siRNAs
derived from native L1 elements; (ii) determining whether
L1 dsRNA is assembled in cis (from the same L1) or if sense
and antisense transcripts originating from two diﬀerent el-
ements (assembly in trans) can also trigger RNAi; and (iii)
perturbing components of the RNAi pathway and seeing if
there are corresponding alterations in the L1 retrotranspo-
sition frequency. Exploration of the ﬁrst area is under active
investigationandisdiscussedindetailelsewhereinthisissue.
Concerningthesecondarea,ithasbeenassumedthatdsRNA
formation in trans is minimal because xenogeneic L1s (eg, a
human element in a mouse cell) do not appear to be more
active than syngeneic L1s (a human element in a human cell)
[32, 68]. However, the permissiveness for L1 retrotransposi-
tion in these diﬀerent cell types is not controlled for. It is in-
triguingthatL1elementsthathavegeneticallymodiﬁedRNA
sequences, but identical protein coding sequences, can be far
more active for retrotransposition [32, 46]. While there are
other potential reasons for this (such as decreased premature
polyadenylation and alterations in RNA structure), it will be
interestingtoseeifsomeoftheenhancedactivityofsynthetic
L 1 si sd u et od i ﬀerent levels of RNAi. The third area of in-
vestigation attempts to establish a mechanistic link between
RNAi and L1 retrotransposition.
Analyzing L1 retrotransposition in cells with altered
RNAi activity is challenging. The ﬁrst obstacle is to moni-
tor the mobilization of an active L1 in a sea of L1 sequences
in the genome. To get around this “needle-in-a-haystack”
problem,L1elementsweretaggedwithantisensemarkercas-
settes interrupted in the sense direction by an intron [52].
These tagged elements could then be monitored for retro-
transposition by scoring for expression of the marker (which
couldonlyoccurafteracycleoftranscription,processing,re-
verse transcription, and integration into a transcriptionally
permissive region of the genome, see Figure 2(a)). Because
the L1 retrotransposition construct contains sense and anti-
sense promoters, it may induce RNAi regardless of whether
the L1 element induces RNAi naturally.
To circumvent the potential problem of having bidirec-
tional transcription in the L1-EGFP construct, we created a
series of EGFP-tagged L1 elements that lacked antisense pro-
moter activity (Figure 2(b)). Using a genetic assay to moni-
tor retrotransposition, our preliminary data reveal a 2-fold
increase in retrotransposition when constructs lacking the
antisense promoter in the EGFP marker were used, com-
pared to the conventional L1-EGFP construct (Figure 2(b)).
To control for length eﬀects (better detection of retrotrans-
position events due to a shorter marker cassette), we created
a construct with a “stuﬀer fragment” in place of the EGFP
promoter. This L1-stuﬀer construct also exhibited increased
retrotransposition compared to the standard L1-EGFP con-
struct, indicating that the basis for the increased retrotrans-
position frequency was due to the absence of promoter ac-
tivity rather than being due to diﬀerences in marker length.
Because the retrotransposition frequency in this assay ap-
proaches 90%, we may be underestimating the true retro-
transposition frequency (there may be more than one inser-
tionperclone).Thebasisfortheincreasedretrotransposition
activity of constructs lacking the antisense promoter driving
the EGFP marker cassette is unresolved. Perhaps these con-
structs will be helpful in future studies that attempt to link
RNAi to the regulation of L1 retrotransposition.
ALTERNATIVE SILENCING PATHWAYS MEDIATED
BY DsRNA
DsRNA can induce several diﬀerent pathways in mammals.
One of them is RNA editing, a process in which adenosines
are converted to inosine in nuclear dsRNA by the enzyme
adenosine deaminase (ADAR). Editing of dsRNA can occur
in a site-selective or promiscuous fashion. The latter results
inthegenerationofaseriesofvariablymutatedRNAspecies.
DsRNA longer than 50bp in which > 20% A-to-I editing has
occurred is referred to as hyperedited [69]. Based largely on
work with polyoma virus, hyperedited RNA may be retained
and/or sequestered in the nucleus [69].
L 1R N Ac a ns e rv ea sas u b s tra t ef o rR N Ae d i t i n g[ 70, 71].
However, the eﬀects of RNA editing on L1 activity are un-
known. Since RNA editing aﬀects dsRNA without target-
ing homologous copies of single-stranded RNA, editing may
have a smaller impact on L1 retrotransposition than RNAi.
If L1 RNA editing is similar to Alu editing, most RNA du-
plexes would be formed intramolecularly due to base pairing
between two oppositely oriented Alus residing in the same
RNA molecule [72]. Such duplexes would be expected to
have imperfect base pairing between neighboring oppositely
oriented L1 elements and could promote editing rather than
RNAi. RNA editing may further help L1 to evade RNAi be-
cause hyperedited L1 dsRNA would be probably processed
less eﬃciently into siRNAs and such siRNAs would not base
pair as well with their targets. This idea is consistent with the
observation that RNAi is antagonized by hyperediting [73]Shane R. Horman et al 5
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Figure 2: (a) The standard L1 reporter construct contains opposing promoters. The standard L1 reporter construct used in our laboratory
(L1-EGFP) consists of the CMV promoter, the human L1RP element, and the antisense EGFP gene cloned into the L1 3 UTR followed by
t h eS V 4 0l a t ep o l y - As e q u e n c ei np C E P 4( c o n s t r u c td e s c r i b e di nm o r ed e t a i li n[ 51]). When L1-EGFP retrotransposes, a full-length L1
RNA is transcribed, the intron interrupting EGFP is spliced out, and the processed RNA is reverse transcribed, and a cDNA copy is inserted
into the genome. If the insertion is of suﬃcient length and enters the genome in a transcriptionally permissive region, retrotransposition
can be detected phenotypically by screening for EGFP expression. Retrotransposition can also be assayed genetically by performing PCR
with primers that ﬂank the EGFP intron. Because the EGFP marker is driven oﬀ of an antisense-oriented promoter relative to the L1,
the potential exists for creating dsRNA. L1 and EGFP transcripts are given by dashed horizontal lines, promoters are denoted with black
arrows, and blue arrows indicate intron-ﬂanking primers used to distinguish new insertions from the parental L1. (b) Loss of an antisense
promoter increases L1 retrotransposition in a cultured cell assay. 143B osteosarcoma cells were transfected with one of the following constructs
as shown in Figure 2(a): L1-EGFP (the same wild-type L1 retrotransposition construct shown in Figure 2(a)), L1-EGFP-DelP (identical to
L1-EGFP except that the CMV promoter driving EGFP was deleted), L1-EGFP-Stuﬀer (identical to L1-EGFP except that the CMV promoter
driving EGFP was replaced with a piece of DNA lacking promoter activity or polyadenylation signals), or L1-EGFP-RIC (retrotransposition
incompetent due to two missense mutations (marked with a red X over the L1 coding sequence) derived from the JM111 L1 mutant [52]).
Boxes indicate coding sequences except for the yellow box in the L1-EGFP-Stuﬀer construct that denotes the stuﬀer sequence. Arrows denote
the promoters and the black line separating the EGFP cassette denotes the intron. Cells were selected in hygromycin for two weeks and
individual clones were picked and expanded. PCR using primers that ﬂank the intron/exon splice site in EGFP (as described in [11]) was
used to monitor individual clones of antibiotic-resistant cells for L1 retrotransposition (loss of the intron in EGFP). The percentages of
clones that had the spliced EGFP are shown in Figure 2(b). The number of clones surveyed for each genotype is given to the right of each of
the bars. None of the retrotransposition incompetent L1 transfectants had a spliced EGFP product.
and that the phenotype of ADAR mutants can be rescued by
mutations in RNAi [74].
In addition to siRNA and RNA editing, longer L1 dsRNA
molecules can induce additional cellular responses [75].
Longer dsRNA molecules can be recognized by the dsRNA-
dependent protein kinase PKR, which, when activated,
results in interferon-mediated activation of the Jak-Stat
pathway and cellular upregulation of interferon-regulated
genes [76]. This mechanism of cytokine defense is an innate
immune response that likely arose to combat viruses, which
frequently produce dsRNA. Activation of PKR by dsRNA
results in its autophosphorylation and subsequent phos-
phorylation of the eukaryotic initiation factor 2α (eIF2α),
causing general inhibition of cellular protein synthesis [76].
Another pathway of dsRNA regulation involves RNaseL,
a potent riboendonuclease. RNaseL can be indirectly trig-
gered by dsRNA through an increase in 2 –5  oligoadeny-
lates. 2 –5  oligoadenylates are produced from ATP by 2 –5 6 Journal of Biomedicine and Biotechnology
oligoadenylate synthetases, which are activated by dsRNA
[77]. In addition to the nucleolytic properties of RNaseL, the
enzymealsoupregulatestypeIinterferongenesbysequester-
ing NFκB transcription factors [77].
Certain cell types, for example those of myeloid origin,
constitutively express receptors that recognize dsRNA [78].
Thetoll-likereceptor(TLR)3recognizesandbindstodsRNA
[79]. TLR3 is expressed on the cell surface as well as in in-
tracellular vesicles [80]. Thus, dsRNA can be recognized by
TLR3 internally, as an intermediate in viral replication, or
externally, as dsRNA leaks from dying cells [78]. Recogni-
tion of dsRNA by TLR3 initiates the binding of NFκBa n d
IRF-3 transcription factors to the promoters of type I inter-
feron genes leading to their upregulation, which can eventu-
ally cause cell death via apoptosis [80].
Mammalian oocytes, embryos, and embryonic stem cells
do not induce a dsRNA-mediated interferon response, but
utilize the RNAi pathway to respond to long dsRNA [14, 15,
81]. In contrast, somatic cells might be more likely to use
an interferon pathway when confronted with long dsRNA
species [82]. The rationale for using diﬀerent dsRNA recog-
nition pathways in progenitor cells versus somatic cells is
that embryos may not be able to aﬀord the luxury of shut-
ting down individual cells if trouble arises. In contrast, adult
mammalian cells can apoptose with little to no eﬀect on the
organism as a whole. It may be that the secondary products
of L1 dsRNA dicer-mediated endonucleolytic cleavage acti-
vate the PKR-interferon pathway in adult diﬀerentiated cells,
which induces cell death.
CONCLUSION
L1 retrotransposons have shaped the mammalian genome
and contribute signiﬁcantly to its mass, yet their mobility
appears to be actively constrained. Along with other cellu-
lar defense mechanisms, RNAi may participate in cell-type-
speciﬁc, multifaceted defense against L1 mobility that in-
cludes RNA destruction, DNA methylation, and heterochro-
matin formation. The development of new genetic models
of RNAi deﬁciency in mammals, coupled with a genetic as-
say for monitoring L1 retrotransposition events, may help to
advance our understanding of how L1 mobility is regulated.
ACKNOWLEDGMENTS
We thank Richard Schultz, Greg Hannon, and members of
theLuningPrakLabforhelpfuldiscussionsandwegratefully
acknowledge Sarah Fox and Janet Sallit for skilled technical
assistance. This work was supported by NIH R01 CA108812
to Eline T Luning Prak and training grant support to Shane
R Horman (T32 CA 09140).
REFERENCES
[1] Tomari Y, Zamore PD. Perspective: machines for RNAi. Genes
& Development. 2005;19(5):517–529.
[2] Carmell MA, Hannon GJ. RNase III enzymes and the initia-
tion of gene silencing. Nature Structural & Molecular Biology.
2004;11(3):214–218.
[3] Plasterk RHA. RNA silencing: the genome’s immune system.
Science. 2002;296(5571):1263–1265.
[4] Bagasra O, Prilliman KR.RNA interference: the molecular im-
mune system. Journal of Molecular Histology. 2004;35(6):545–
553.
[5] Sijen T, Plasterk RHA. Transposon silencing in the Caenor-
habditis elegans germ line by natural RNAi. Nature. 2003;
426(6964):310–314.
[6] VastenhouwNL,PlasterkRHA.RNAiprotectstheCaenorhab-
ditis elegans germline against transposition. Trends in Genet-
ics. 2004;20(7):314–319.
[7] Jensen S, Gassama M-P, Heidmann T. Taming of transposable
elements by homology-dependent gene silencing. Nature Ge-
netics. 1999;21(2):209–212.
[8] Jensen S, Gassama M-P, Heidmann T. Cosuppression of I
transposon activity in Drosophila by I-containing sense and
antisense transgenes. Genetics. 1999;153(4):1767–1774.
[9] Aravin AA, Naumova NM, Tulin AV, Vagin VV, Rozovsky
YM, Gvozdev VA. Double-stranded RNA-mediated silencing
of genomic tandem repeats and transposable elements in the
D.melanogaster germline. CurrentBiology. 2001;11(13):1017–
1027.
[10] Kalmykova AI, Klenov MS, Gvozdev VA. Argonaute pro-
tein PIWI controls mobilization of retrotransposons in the
Drosophila male germline. Nucleic Acids Research. 2005;33(6):
2052–2059.
[11] Prak ETL, Dodson AW, Farkash EA, Kazazian HH Jr. Tracking
an embryonic L1 retrotransposition event. Proceedings of the
National Academy of Sciences of the United States of America.
2003;100(4):1832–1837.
[12] Branciforte D, Martin SL. Developmental and cell type
speciﬁcity of LINE-1 expression in mouse testis: implica-
tions for transposition. Molecular and Cellular Biology. 1994;
14(4):2584–2592.
[13] Ostertag EM, DeBerardinis RJ, Goodier JL, et al. A mouse
model of human L1 retrotransposition. Nature Genetics. 2002;
32(4):655–660.
[14] Svoboda P. Long dsRNA and silent genes strike back: RNAi
in mouse oocytes and early embryos. Cytogenetic and Genome
Research. 2004;105(2–4):422–434.
[15] Stein P, Zeng F, Pan H, Schultz RM. Absence of non-
speciﬁc eﬀects of RNA interference triggered by long double-
stranded RNA in mouse oocytes. Developmental Biology.
2005;286(2):464–471.
[16] Lander ES, Linton LM, Birren B, et al. Initial sequencing and
analysis of the human genome. Nature. 2001;409(6822):860–
921.
[17] BrouhaB,Schustak J,Badge RM,et al. HotL1s account for the
bulk of retrotransposition in the human population. Proceed-
ings of the National Academy of Sciences of the United States of
America. 2003;100(9):5280–5285.
[18] Luning Prak ET, Kazazian HH Jr. Mobile elements and the hu-
man genome. Nature Reviews. Genetics. 2000;1(2):134–144.
[19] Han JS, Szak ST, Boeke JD. Transcriptional disruption by the
L1 retrotransposon and implications for mammalian tran-
scriptomes. Nature. 2004;429(6989):268–274.
[20] Han JS, Boeke JD. LINE-1 retrotransposons: modulators of
quantity and quality of mammalian gene expression? BioEs-
says. 2005;27(8):775–784.
[21] Moran JV, DeBerardinis RJ, Kazazian HH Jr. Exon shuﬄing by
L1 retrotransposition. Science. 1999;283(5407):1530–1534.
[22] Pickeral OK, Makaowski W, Boguski MS, Boeke JD. Frequent
human genomic DNA transduction driven by LINE-1 retro-
transposition. Genome Research. 2000;10(4):411–415.Shane R. Horman et al 7
[23] Goodier JL, Ostertag EM, Kazazian HH Jr. Transduction of 3 -
ﬂanking sequences is common in L1 retrotransposition. Hu-
man Molecular Genetics. 2000;9(4):653–657.
[24] Dewannieux M, Esnault C, Heidmann T. LINE-mediated
retrotransposition of marked Alu sequences. Nature Genetics.
2003;35(1):41–48.
[25] KazazianHHJr.Mobileelementsanddisease.Current Opinion
in Genetics & Development. 1998;8(3):343–350.
[ 2 6 ] M u o triA R ,C h uV T ,M a r c h e t t oM C ,D e n gW ,M o ra nJ V ,G a g e
FH. Somatic mosaicism in neuronal precursor cells mediated
by L1 retrotransposition. Nature. 2005;435(7044):903–910.
[27] Boissinot S, Entezam A, Furano AV. Selection against delete-
rious LINE-1-containing loci in the human lineage. Molecular
Biology and Evolution. 2001;18(6):926–935.
[28] BoissinotS, RoosC,Furano AV. Diﬀerent rates of LINE-1 (L1)
retrotransposon ampliﬁcation and evolution in New World
monkeys. Journal of Molecular Evolution. 2004;58(1):122–130.
[29] Goto T, Jones GM, Lolatgis N, Pera MF, Trounson AO,
Monk M. Identiﬁcation and characterisation of known and
novel transcripts expressed during the ﬁnal stages of human
oocyte maturation. Molecular Reproduction and Development.
2002;62(1):13–28.
[30] Ergun S, Buschmann C, Heukeshoven J, et al. Cell type-
speciﬁc expression of LINE-1 open reading frames 1 and 2 in
fetal and adult human tissues. The Journal of Biological Chem-
istry. 2004;279(26):27753–27763.
[31] Yang N, Zhang L, Zhang Y, Kazazian HH Jr. An important role
forRUNX3inhumanL1transcriptionandretrotransposition.
Nucleic Acids Research. 2003;31(16):4929–4940.
[32] Han JS, Boeke JD. A highly active synthetic mammalian retro-
transposon. Nature. 2004;429(6989):314–318.
[33] Wei W, Gilbert N, Ooi SL, et al. Human L1 retrotransposition:
cis preference versus trans complementation. Molecular and
Cellular Biology. 2001;21(4):1429–1439.
[34] Esnault C, Maestre J, Heidmann T. Human LINE retro-
transposons generate processed pseudogenes. Nature Genetics.
2000;24(4):363–367.
[35] Boissinot S, Chevret P, Furano AV. L1 (LINE-1) retrotrans-
poson evolution and ampliﬁcation in recent human history.
Molecular Biology and Evolution. 2000;17(6):915–928.
[36] SkowronskiJ,FanningTG,SingerMF.Unit-lengthline-1tran-
scriptsinhumanteratocarcinomacells.MolecularandCellular
Biology. 1988;8(4):1385–1397.
[37] Kramerov DA, Bukrinsky MI, Ryskov AP. DNA sequences
homologous to long double-stranded RNA. Transcription
of intracisternal A-particle genes and major long repeat
of the mouse genome. Biochimica et Biophysica Acta.
1985;826(1):20–29.
[38] Martens JH, O’Sullivan RJ, Braunschweig U, et al. The pro-
ﬁleofrepeat-associatedhistonelysinemethylationstatesinthe
mouse epigenome. The EMBO Journal. 2005;24(4):800–812.
[39] Houbaviy HB, Murray MF, Sharp PA. Embryonic stem cell-
speciﬁc MicroRNAs. Developmental Cell. 2003;5(2):351–358.
[40] Suh MR, Lee Y, Kim JY, et al. Human embryonic stem cells
express a unique set of microRNAs. Developmental Biology.
2004;270(2):488–498.
[41] Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identi-
ﬁcation of novel genes coding for small expressed RNAs. Sci-
ence. 2001;294(5543):853–858.
[42] Speek M. Antisense promoter of human L1 retrotransposon
drives transcription of adjacent cellular genes. Molecular and
Cellular Biology. 2001;21(6):1973–1985.
[43] Nigumann P, Redik K, Matlik K, Speek M. Many human genes
are transcribed from the antisense promoter of L1 retrotrans-
poson. Genomics. 2002;79(5):628–634.
[44] Szak ST, Pickeral OK, Makalowski W, Boguski MS, Landsman
D, Boeke JD. Molecular archeology of L1 insertions in the hu-
man genome. Genome Biology. 2002;3(10):research0052.
[45] Ostertag EM, Kazazian HH Jr. Twin priming: a proposed
m e c h a n i s mf o rt h ec r e a t i o no fi n v e r s i o n si nL 1r e t r o t r a n s p o -
sition. Genome Research. 2001;11(12):2059–2065.
[46] Perepelitsa-Belancio V, Deininger P. RNA truncation by pre-
mature polyadenylation attenuates human mobile element ac-
tivity. Nature Genetics. 2003;35(4):363–366.
[47] Svoboda P, Stein P, Anger M, Bernstein E, Hannon GJ, Schultz
RM. RNAi and expression of retrotransposons MuERV-L and
IAP in preimplantation mouse embryos. Developmental Biol-
ogy. 2004;269(1):276–285.
[48] Kanellopoulou C, Muljo SA, Kung AL, et al. Dicer-deﬁcient
mouse embryonic stem cells are defective in diﬀerenti-
ation and centromeric silencing. Genes & Development.
2005;19(4):489–501.
[49] Soifer HS, Zaragoza A, Peyvan M, Behlke MA, Rossi JJ. A po-
tential role for RNA interference in controlling the activity of
the human LINE-1 retrotransposon. Nucleic Acids Research.
2005;33(3):846–856.
[50] Yang N, Zhang L, Kazazian HH Jr. L1 retrotransposon-
mediated stable gene silencing. Nucleic Acids Research.
2005;33(6):e57.
[51] Ostertag EM, Prak ET, DeBerardinis RJ, Moran JV, Kazazian
HH Jr. Determination of L1 retrotransposition kinetics in cul-
tured cells. Nucleic Acids Research. 2000;28(6):1418–1423.
[52] Moran JV, Holmes SE, Naas TP, DeBerardinis RJ, Boeke JD,
Kazazian HH Jr. High frequency retrotransposition in cul-
tured mammalian cells. Cell. 1996;87(5):917–927.
[53] Bestor TH. The host defence function of genomic methylation
patterns. Novartis Foundation Symposium. 1998;214:187–195.
discussion 195–199, 228–232.
[54] Bestor TH. Cytosine methylation mediates sexual conﬂict.
Trends in Genetics. 2003;19(4):185–190.
[55] Woodcock DM, Lawler CB, Linsenmeyer ME, Doherty JP,
Warren WD. Asymmetric methylation in the hypermethylated
CpG promoter region of the human L1 retrotransposon. The
Journal of Biological Chemistry. 1997;272(12):7810–7816.
[56] Burden AF, Manley NC, Clark AD, Gartler SM, Laird
CD, Hansen RS. Hemimethylation and non-CpG methyla-
tion levels in a promoter region of human LINE-1 (L1)
repeated elements. The Journal of Biological Chemistry.
2005;280(15):14413–14419.
[57] Tchenio T, Segal-Bendirdjian E, Heidmann T. Generation of
processed pseudogenes in murine cells. The EMBO Journal.
1993;12(4):1487–1497.
[58] Walsh CP, Chaillet JR, Bestor TH. Transcription of IAP en-
dogenous retroviruses is constrained by cytosine methylation.
Nature Genetics. 1998;20(2):116–117.
[59] Bourc’his D, Bestor TH. Meiotic catastrophe and retrotrans-
posonreactivationinmalegermcellslackingDnmt3L.Nature.
2004;431(7004):96–99.
[60] Ting AH, Schuebel KE, Herman JG, Baylin SB. Short double-
stranded RNA induces transcriptional gene silencing in hu-
man cancer cells in the absence of DNA methylation. Nature
Genetics. 2005;37(8):906–910.
[61] Verdel A, Jia S, Gerber S, et al. RNAi-mediated target-
ing of heterochromatin by the RITS complex. Science.
2004;303(5658):672–676.8 Journal of Biomedicine and Biotechnology
[62] Cam HP, Sugiyama T, Chen ES, Chen X, FitzGerald PC,
Grewal SI. Comprehensive analysis of heterochromatin- and
RNAi-mediatedepigeneticcontroloftheﬁssionyeastgenome.
Nature Genetics. 2005;37(8):809–819.
[63] Nolan T, Braccini L, Azzalin G, De Toni A, Macino G, Cogoni
C. The post-transcriptional gene silencing machinery func-
tions independently of DNA methylation to repress a LINE1-
like retrotransposon in Neurospora crassa. Nucleic Acids Re-
search. 2005;33(5):1564–1573.
[64] Lippman Z, Gendrel AV, Black M, et al. Role of transposable
elements in heterochromatin and epigenetic control. Nature.
2004;430(6998):471–476.
[65] BirchlerJA,BhadraMP,BhadraU.Makingnoiseaboutsilence:
repression of repeated genes in animals. Current Opinion in
Genetics & Development. 2000;10(2):211–216.
[66] Bender J. DNA methylation and epigenetics. Annual Review of
Plant Biology. 2004;55:41–68.
[67] Lippman Z, May B, Yordan C, Singer T, Martienssen R.
Distinct mechanisms determine transposon inheritance and
methylation via small interfering RNA and histone modiﬁca-
tion. PLoS Biology. 2003;1(3):E67.
[68] Naas TP, DeBerardinis RJ, Moran JV, et al. An actively retro-
transposing, novel subfamily of mouse L1 elements. The
EMBO Journal. 1998;17(2):590–597.
[69] DeCerbo J, Carmichael GG. Retention and repression: fates of
hyperedited RNAs in the nucleus. Current Opinion in Cell Bi-
ology. 2005;17(3):302–308.
[70] BlowM,FutrealPA,WoosterR,StrattonMR.AsurveyofRNA
editing in human brain. Genome Research. 2004;14(12):2379–
2387.
[71] Levanon EY, Eisenberg E, Yelin R, et al. Systematic identiﬁca-
tion of abundant A-to-I editing sites in the human transcrip-
tome. Nature Biotechnology. 2004;22(8):1001–1005.
[72] Athanasiadis A, Rich A, Maas S. Widespread A-to-I RNA edit-
ing of Alu-containing mRNAs in the human transcriptome.
PLoS Biology. 2004;2(12):e391.
[73] Scadden AD, Smith CW. RNAi is antagonized by A → Ih yp e r -
editing. EMBO Reports. 2001;2(12):1107–1111.
[74] Tonkin LA, Bass BL. Mutations in RNAi rescue aberrant
chemotaxis of ADAR mutants. Science. 2003;302(5651):1725.
[75] BillyE,BrondaniV,ZhangH,M¨ ullerU,FilipowiczW.Speciﬁc
interference with gene expression induced by long, double-
strandedRNAinmouseembryonalteratocarcinomacelllines.
Proceedings of the National Academy of Sciences of the United
States of America. 2001;98(25):14428–14433.
[76] Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BR.
Activation of the interferon system by short-interfering RNAs.
Nature Cell Biology. 2003;5(9):834–839.
[77] Castelli JC, Hassel BA, Maran A, et al. The role of 2 –5 
oligoadenylate-activated ribonuclease L in apoptosis. Cell
Death and Diﬀerentiation. 1998;5(4):313–320.
[78] Guillot L, Le Goﬃc R, Bloch S, et al. Involvement of toll-like
receptor 3 in the immune response of lung epithelial cells to
double-stranded RNA and inﬂuenza A virus. The Journal of
Biological Chemistry. 2005;280(7):5571–5580.
[79] MatsumotoM,KikkawaS,KohaseM,MiyakeK,SeyaT.Estab-
lishment of a monoclonal antibody against human Toll-like
receptor 3 that blocks double-stranded RNA-mediated sig-
naling. Biochemical and Biophysical Research Communications.
2002;293(5):1364–1369.
[80] Matsumoto M, Funami K, Oshiumi H, Seya T. Toll-like recep-
tor 3: a link between toll-like receptor, interferon and viruses.
Microbiology and Immunology. 2004;48(3):147–154.
[81] Paddison PJ, Caudy AA, Hannon GJ. Stable suppression of
gene expression by RNAi in mammalian cells. Proceedings of
the National Academy of Sciences of the United States of Amer-
ica. 2002;99(3):1443–1448.
[82] Saunders LR, Barber GN. The dsRNA binding protein fam-
ily:criticalroles,diversecellularfunctions.TheFASEBJournal.
2003;17(9):961–983.